Sg Americas Securities, LLC Abb Vie Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 24,359 shares of ABBV stock, worth $4.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,359

Previous 244,630 90.04%

Holding current value

$4.59 Million

Previous $42 Million 88.54%

% of portfolio

0.02%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$163.84 - $199.33 $36.1 Million - $43.9 Million	-220,271 Reduced 90.04%	24,359 $4.81 Million
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $38.3 Million - $44.7 Million	-247,430 Reduced 50.28%	244,630 $42 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $48.8 Million - $55.6 Million	-305,282 Reduced 38.29%	492,060 $89.6 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $76.3 Million - $85.9 Million	554,482 Added 228.31%	797,342 $124 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $22.9 Million - $26.5 Million	-171,540 Reduced 41.39%	242,860 $36.2 Million
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $25.8 Million - $32.1 Million	194,526 Added 88.47%	414,400 $55.8 Million
Q1 2023 Apr 28, 2023	BUY	$144.61 - $166.54 $26.9 Million - $31 Million	186,211 Added 553.16%	219,874 $35 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $36.1 Million - $43.3 Million	-260,791 Reduced 88.57%	33,663 $5.44 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $3.51 Million - $4.02 Million	26,148 Added 9.75%	294,454 $39.5 Million
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $9.41 Million - $12 Million	68,379 Added 34.2%	268,306 $41.1 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $29.4 Million - $36.4 Million	-222,533 Reduced 52.68%	199,927 $32.4 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $28.5 Million - $36.1 Million	265,242 Added 168.71%	422,460 $57.2 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $17.9 Million - $20.3 Million	-167,878 Reduced 51.64%	157,218 $17 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $16 Million - $17.8 Million	152,017 Added 87.83%	325,096 $36.6 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $4.32 Million - $4.76 Million	-42,235 Reduced 19.62%	173,079 $18.7 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $11.1 Million - $15 Million	138,352 Added 179.77%	215,314 $23.1 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $2.89 Million - $3.39 Million	-33,600 Reduced 30.39%	76,962 $6.74 Million
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $117,392 - $157,088	1,600 Added 1.47%	110,562 $10.9 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $852,367 - $1.29 Million	13,215 Added 13.8%	108,962 $8.3 Million
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $6.39 Million - $8 Million	88,653 Added 1249.69%	95,747 $8.48 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $24.7 Million - $29.7 Million	-391,818 Reduced 98.22%	7,094 $537,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $15.3 Million - $19.6 Million	233,032 Added 140.48%	398,912 $29 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $9.12 Million - $10.7 Million	-118,169 Reduced 41.6%	165,880 $13.4 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $20.8 Million - $25.6 Million	-266,943 Reduced 48.45%	284,049 $26.2 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $27.9 Million - $31.1 Million	314,285 Added 132.77%	550,992 $52.1 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $61.5 Million - $72.8 Million	-685,256 Reduced 74.33%	236,707 $21.9 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $52.5 Million - $70.2 Million	570,075 Added 162.0%	921,963 $87.3 Million
Q4 2017 Jan 24, 2018	BUY	$89.56 - $98.21 $28 Million - $30.7 Million	312,277 Added 788.36%	351,888 $34 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $2.77 Million - $3.53 Million	39,611	39,611 $3.52 Million

Others Institutions Holding ABBV

# of Institutions

3,732

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.8M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $333B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Abb Vie Inc. Transaction History